Explore 3 Stock Ideas & Industry Insights Download Free Report

Technology

Strait of Hormuz Crisis: How Middle East Tensions Triggered the Nasdaq's 4.5% Selloff and What the Ceasefire Means for Tech Stocks

The Strait of Hormuz — the narrow waterway between Iran and the Arabian Peninsula through which approximately 20% of global oil supply transits daily — is one of the most strategically significant chokepoints in the global economy. When U.S.-Iran tensions escalate around the Strait, …

Vinay Lochav | 29 June 2026

Is the AI Investment Bubble Real? Breaking Down the 2026 Semiconductor Valuation Debate

The most important debate in technology investing in 2026 centers on whether AI infrastructure spending — the $200 billion-plus annual capex commitment from Microsoft, Amazon, Google, and Meta — is generating sufficient return on investment to sustain at current levels, or whether a spending …

Vinay Lochav | 29 June 2026

Russell Index Reconstitution Explained: How Passive Investing Creates Trading Opportunities in 2026

The Russell index annual reconstitution — conducted each June — is the process by which FTSE Russell reshuffles the composition of its equity benchmarks, including the Russell 1000, Russell 2000, Russell 3000, and their growth and value sub-indices. Stocks are reassigned based on market …

Vinay Lochav | 29 June 2026

Healthcare Sector Rotation 2026: Why XLV Is Hitting 52-Week Highs as Tech Sells Off

The healthcare sector ETF (XLV) posted its best weekly outperformance versus the S&P 500 on record, approaching 52-week highs as institutional investors rotated aggressively out of technology and into healthcare names during the AI infrastructure hardware selloff. The rotation reflects a fundamental reassessment of …

Vinay Lochav | 29 June 2026

ASML Stock (ASML) Rises 2% — EUV Monopoly Makes It a 'Must-Own' AI Chip Infrastructure Stock Despite China Risk

ASML Holding (NASDAQ: ASML) shares are rising nearly 2% in Monday's session, outperforming a semiconductor sector that is still recovering from last week's AI-driven selloff. The Dutch lithography equipment maker's relative outperformance underscores investors' recognition of its unique, irreplaceable structural position in the semiconductor …

Vinay Lochav | 29 June 2026

EUV Lithography Explained: How ASML's Monopoly Powers Every AI Chip and Why It Makes ASML a Core Portfolio Holding

Extreme ultraviolet lithography is the manufacturing process used to print the microscopic circuit patterns that define advanced semiconductor chips at 7nm, 5nm, 3nm, and smaller dimensions. The process uses 13.5-nanometer wavelength light — so short that it is in the X-ray range — to …

Vinay Lochav | 29 June 2026

MINISO Stock (MNSO) Surges on HK$2 Billion Share Buyback Program — Management Signals Undervaluation

MINISO Group (NYSE: MNSO) shares surged following the company's announcement of a new HK$2 billion share repurchase program set to begin June 30, 2026. The buyback announcement — covering both ordinary shares and American depositary shares over a 12-month period — signals strong board …

Vinay Lochav | 29 June 2026

XPeng Stock (XPEV) — X-Mind AI Unveiled at CVPR 2026 as Deliveries Fall 33% and Losses Widen

XPeng (NYSE: XPEV) shares remain near 52-week lows, trading in a challenging zone where impressive technology announcements are failing to offset deteriorating operational metrics. Monday's unveiling of the X-Mind Predictive World Model at the CVPR 2026 Workshop — while technically significant — has not …

Vinay Lochav | 29 June 2026

China EV Price War 2026: How XPeng (XPEV), BYD, and Li Auto Are Fighting for Market Survival

China's electric vehicle market has become the most competitive automotive market in the world, with over 100 EV brands competing for consumer attention in a market where price cuts, technology upgrades, and range improvements occur at a pace that would be unimaginable in Western …

Vinay Lochav | 29 June 2026

Prime Medicine Stock (PRME) Surges 10% — First-Ever In Vivo Prime Editing Clinical Authorization and Russell Index Addition

Prime Medicine (NASDAQ: PRME) shares are surging nearly 10% in Monday's session, driven by a confluence of catalysts that are fundamentally reshaping the investment narrative around the gene-editing company. The most significant development — New Zealand's clearance of PM577a's Clinical Trial Application — represents …

Vinay Lochav | 29 June 2026
Support

Hi! How can we help you today?

Loading…